Xenon Pharmaceuticals XENE Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Xenon Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Xenon Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xenon Pharmaceuticals's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xenon Pharmaceuticals's net margin?
- Xenon Pharmaceuticals (XENE) reported net margin of -4,612.1% in Q4 2025.
- What is the long-term trend for Xenon Pharmaceuticals's net margin?
- Over 3 years (2020 to 2025), Xenon Pharmaceuticals's net margin has grown at a 271.9% compound annual growth rate (CAGR), from -89.7% to -4,612.1%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.